Cannabinoid receptors in the central nervous system: their signaling and roles in disease

DA Kendall, GA Yudowski - Frontiers in cellular neuroscience, 2017 - frontiersin.org
The identification and cloning of the two major cannabinoid (CB1 and CB2) receptors
together with the discovery of their endogenous ligands in the late 80s and early 90s …

Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it's been…

EP Baron - Headache: The Journal of Head and Face Pain, 2015 - Wiley Online Library
Background The use of cannabis, or marijuana, for medicinal purposes is deeply rooted
though history, dating back to ancient times. It once held a prominent position in the history …

The impact of marijuana policies on youth: clinical, research, and legal update

S Ammerman, S Ryan, WP Adelman… - …, 2015 - publications.aap.org
This Technical Report was reaffirmed January 2024. This technical report updates the 2004
American Academy of Pediatrics technical report on the legalization of marijuana. Current …

New insights and potential therapeutic targeting of CB2 cannabinoid receptors in CNS disorders

BG Kibret, H Ishiguro, Y Horiuchi, ES Onaivi - International journal of …, 2022 - mdpi.com
The endocannabinoid system (ECS) is ubiquitous in most human tissues, and involved in
the regulation of mental health. Consequently, its dysregulation is associated with …

Monoacylglycerol lipase is a therapeutic target for Alzheimer's disease

R Chen, J Zhang, Y Wu, D Wang, G Feng, YP Tang… - Cell reports, 2012 - cell.com
Alzheimer's disease (AD) is the most common cause of dementia among older people.
There are no effective medications currently available to prevent and treat AD and halt …

New insights in cannabinoid receptor structure and signaling

L Ye, Z Cao, W Wang, N Zhou - Current molecular …, 2019 - ingentaconnect.com
Background: Cannabinoid has long been used for medicinal purposes. Cannabinoid
signaling has been considered the therapeutic target for treating pain, addiction, obesity …

[HTML][HTML] Monoacylglycerol lipase inhibitors: modulators for lipid metabolism in cancer malignancy, neurological and metabolic disorders

H Deng, W Li - Acta Pharmaceutica Sinica B, 2020 - Elsevier
Monoacylglycerol lipase (MAGL) is a serine hydrolase that plays a crucial role catalysing the
hydrolysis of monoglycerides into glycerol and fatty acids. It links the endocannabinoid and …

Medical cannabis for chronic nonmalignant pain management

M Hameed, S Prasad, E Jain, BN Dogrul… - Current Pain and …, 2023 - Springer
Abstract Purpose of Review Cannabis has been used since ancient times for medical and
recreational research. This review article will document the validity of how medical cannabis …

Therapeutic potential of monoacylglycerol lipase inhibitors

MM Mulvihill, DK Nomura - Life sciences, 2013 - Elsevier
Marijuana and aspirin have been used for millennia to treat a wide range of maladies
including pain and inflammation. Both cannabinoids, like marijuana, that exert anti …

Cannabis (medical marijuana) treatment for motor and non–motor symptoms of Parkinson disease: An open-label observational study

I Lotan, TA Treves, Y Roditi… - Clinical …, 2014 - journals.lww.com
Objective The use of cannabis as a therapeutic agent for various medical conditions has
been well documented. However, clinical trials in patients with Parkinson disease (PD) have …